Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?

PloS One
Vivien AlessandriniFrançois Goffinet

Abstract

Although vaccination against influenza is recommended for pregnant women in France because it exposes them to a risk of death and severe respiratory complications, their vaccination coverage in 2016 was estimated at 7%. This study's principal objective was to assess the association between the availability of influenza vaccination at prenatal care visits and vaccination coverage. This multicenter survey took place in 3 Paris-area public hospital (AP-HP) maternity wards (A, B, and C). Only maternity ward A offered the vaccine and vaccination without charge at prenatal visits. Data were collected from parturients during 10 days in January 2017 by a self-administered anonymous questionnaire. Data from 248 women showed overall vaccination coverage of 19.4% (48/248): 35.4% (46/130) in maternity unit A, 2.7% (2/75) in B, and 0% (0/43) in C (P<0.01). After adjustment for socio-demographic characteristics, women at maternity ward A were significantly more likely to be vaccinated than those at B and C (aOR 25.52, 95%CI [5.76-113.10]). Other factors significantly associated with higher vaccination coverage were the mother's French birth (aOR 2.37 CI [1.03-5.46]) and previous influenza vaccination (aOR 3.13, 95%CI [1.25-7.86]). Vaccinated...Continue Reading

References

Jan 31, 2006·American Journal of Epidemiology·Michael W LinkPascale M Wortley
Sep 19, 2008·The New England Journal of Medicine·K ZamanMark C Steinhoff
Mar 24, 2010·Obstetrics and Gynecology·Andreea A CreangaMargaret A Honein
Apr 22, 2010·JAMA : the Journal of the American Medical Association·Alicia M SistonUNKNOWN Pandemic H1N1 Influenza in Pregnancy Working Group
Apr 30, 2010·The New England Journal of Medicine·Mark C SteinhoffKhalequ Zaman M B B S
Jun 11, 2010·Journal of the American Geriatrics Society·Shauna T LinnKushang V Patel
Oct 6, 2010·Archives of Pediatrics & Adolescent Medicine·Angelia A EickKatherine L O'Brien
Nov 6, 2010·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Mark H YudinMichael D Sgro
Feb 25, 2011·American Journal of Obstetrics and Gynecology·Ilona GoldfarbLaura Riley
Jun 7, 2011·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Sachi SakaguchiAdrienne Einarson
Jun 10, 2011·American Journal of Obstetrics and Gynecology·Denise J JamiesonCindy Weinbaum
Jun 10, 2011·American Journal of Obstetrics and Gynecology·Dmitry FridmanHoward Minkoff
Jun 16, 2011·BMJ : British Medical Journal·Matthias PierceUNKNOWN UKOSS
Feb 3, 2012·Maternal and Child Health Journal·Marie TarrantVincci Hiu Sze Chan
Feb 22, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Geraldine Blanchard-RohnerClaire-Anne Siegrist
Jan 18, 2013·The New England Journal of Medicine·Siri E HåbergCamilla Stoltenberg
May 3, 2013·Obstetrics and Gynecology·James D NordinAvalow Olsen
Aug 8, 2013·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·C ChangY Cui
Sep 11, 2013·Vaccine·Carol Yuet Sheung YuenMarie Tarrant
Sep 4, 2014·The New England Journal of Medicine·Shabir A MadhiUNKNOWN Maternal Flu Trial (Matflu) Team
Nov 5, 2014·Expert Opinion on Drug Safety·Paul LoubetOdile Launay
Nov 20, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kristin N BrattonSaad B Omer
Apr 16, 2015·Journal of Women's Health·Michelle L HenningerUNKNOWN Influenza Project (PIP) Working Group
Apr 22, 2015·Vaccine·Noni E MacDonald, UNKNOWN SAGE Working Group on Vaccine Hesitancy
Jun 20, 2015·Frontiers in Immunology·Alexander W Kay, Catherine A Blish
Oct 25, 2016·Women and Birth : Journal of the Australian College of Midwives·Annette K ReganPaul V Effler
Jul 9, 2016·PloS One·Melissa B GilkeyNoel T Brewer
Oct 26, 2016·EBioMedicine·Heidi J LarsonNick S Jones
Jan 11, 2017·BMC Infectious Diseases·Francesco NapolitanoItalo Francesco Angelillo
May 20, 2017·The Lancet Infectious Diseases·Mark C SteinhoffJames M Tielsch
Sep 29, 2017·MMWR. Morbidity and Mortality Weekly Report·Helen DingStacie M Greby
Mar 7, 2018·Vaccine·Jeremy K WardPierre Verger
Apr 12, 2018·Human Vaccines & Immunotherapeutics·Francesco NapolitanoItalo Francesco Angelillo
Jun 5, 2018·Human Vaccines & Immunotherapeutics·Alessia D'AlessandroItalo Francesco Angelillo
Nov 10, 2018·Médecine et maladies infectieuses·R CohenA Martinot

❮ Previous
Next ❯

Citations

Nov 15, 2019·Human Vaccines & Immunotherapeutics·Alexandre DescampsBéatrice Blondel
Jan 24, 2020·MMWR. Morbidity and Mortality Weekly Report·Taylor A MerrittLindsay A Thompson
Sep 3, 2020·Human Vaccines & Immunotherapeutics·Helen SkirrowBeate Kampmann
Dec 29, 2020·Médecine et maladies infectieuses·S Bessis

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.